CorMedix Total Cash From Financing Activities from 2010 to 2024

CRMD Stock  USD 8.57  0.30  3.38%   
CorMedix's Total Cash From Financing Activities is increasing over the years with slightly volatile fluctuation. Overall, Total Cash From Financing Activities is expected to go to about 58.7 M this year. During the period from 2010 to 2024 CorMedix Total Cash From Financing Activities annual values regression line had geometric mean of  16,379,957 and mean square error of 171.1 T. View All Fundamentals
 
Total Cash From Financing Activities  
First Reported
2007-12-31
Previous Quarter
1.1 M
Current Value
14.1 M
Quarterly Volatility
10.1 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check CorMedix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CorMedix's main balance sheet or income statement drivers, such as Interest Expense of 32.6 K, Selling General Administrative of 37.6 M or Research Development of 10.2 M, as well as many indicators such as Price To Sales Ratio of 1.6 K, Dividend Yield of 0.0179 or PTB Ratio of 2.87. CorMedix financial statements analysis is a perfect complement when working with CorMedix Valuation or Volatility modules.
  
Check out the analysis of CorMedix Correlation against competitors.
For information on how to trade CorMedix Stock refer to our How to Trade CorMedix Stock guide.

Latest CorMedix's Total Cash From Financing Activities Growth Pattern

Below is the plot of the Total Cash From Financing Activities of CorMedix over the last few years. It is CorMedix's Total Cash From Financing Activities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CorMedix's overall financial position and show how it may be relating to other accounts over time.
Total Cash From Financing Activities10 Years Trend
Slightly volatile
   Total Cash From Financing Activities   
       Timeline  

CorMedix Total Cash From Financing Activities Regression Statistics

Arithmetic Mean25,489,581
Geometric Mean16,379,957
Coefficient Of Variation74.74
Mean Deviation15,585,429
Median23,863,845
Standard Deviation19,052,042
Sample Variance363T
Range57.6M
R-Value0.75
Mean Square Error171.1T
R-Squared0.56
Significance0
Slope3,194,834
Total Sum of Squares5081.7T

CorMedix Total Cash From Financing Activities History

202458.7 M
202355.9 M
202217.9 M
202141.8 M
202040.1 M
201925.8 M
201829.4 M

About CorMedix Financial Statements

CorMedix stakeholders use historical fundamental indicators, such as CorMedix's Total Cash From Financing Activities, to determine how well the company is positioned to perform in the future. Although CorMedix investors may analyze each financial statement separately, they are all interrelated. For example, changes in CorMedix's assets and liabilities are reflected in the revenues and expenses on CorMedix's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in CorMedix. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Cash From Financing Activities55.9 M58.7 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether CorMedix is a strong investment it is important to analyze CorMedix's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CorMedix's future performance. For an informed investment choice regarding CorMedix Stock, refer to the following important reports:
Check out the analysis of CorMedix Correlation against competitors.
For information on how to trade CorMedix Stock refer to our How to Trade CorMedix Stock guide.
You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CorMedix. If investors know CorMedix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CorMedix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.80)
Revenue Per Share
0.212
Quarterly Revenue Growth
(0.47)
Return On Assets
(0.38)
Return On Equity
(0.65)
The market value of CorMedix is measured differently than its book value, which is the value of CorMedix that is recorded on the company's balance sheet. Investors also form their own opinion of CorMedix's value that differs from its market value or its book value, called intrinsic value, which is CorMedix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CorMedix's market value can be influenced by many factors that don't directly affect CorMedix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CorMedix's value and its price as these two are different measures arrived at by different means. Investors typically determine if CorMedix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CorMedix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.